WKN: A0MXL8
Land:USA
ISIN: US45248L3087
Marktkapitalisierung: 8,44 Mio.
Streubesitz: n.a.
Branche:Pharma
ImaRx Therapeutics, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for vascular disorders in the United States. Its commercialization efforts are focused on urokinase, a thrombolytic drug used for the treatment of acute massive pulmonary embolism, or blood clots in the lungs.
News
ImaRx Therapeutics Signs Letter of Intent With Microbix Biosystems for the Sale of Urokinase:...lesen unter biz.yahoo.com/prnews/080507/nyw080.html?.v=101
Chart
Land:USA
ISIN: US45248L3087
Marktkapitalisierung: 8,44 Mio.
Streubesitz: n.a.
Branche:Pharma
ImaRx Therapeutics, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for vascular disorders in the United States. Its commercialization efforts are focused on urokinase, a thrombolytic drug used for the treatment of acute massive pulmonary embolism, or blood clots in the lungs.
News
ImaRx Therapeutics Signs Letter of Intent With Microbix Biosystems for the Sale of Urokinase:...lesen unter biz.yahoo.com/prnews/080507/nyw080.html?.v=101
Chart
(Verkleinert auf 90%) 
